ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 242 filers reported holding ACCELERON PHARMA INC in Q3 2020. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $634,000 | -19.4% | 3,686 | -41.2% | 0.00% | -20.0% |
| Q2 2021 | $787,000 | -7.4% | 6,268 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $850,000 | +11.3% | 6,268 | +5.0% | 0.01% | 0.0% |
| Q4 2020 | $764,000 | +82.3% | 5,968 | +60.2% | 0.01% | +66.7% |
| Q3 2020 | $419,000 | +22.9% | 3,726 | +4.2% | 0.00% | 0.0% |
| Q2 2020 | $341,000 | +196.5% | 3,576 | +178.3% | 0.00% | +200.0% |
| Q1 2020 | $115,000 | +35.3% | 1,285 | -19.9% | 0.00% | 0.0% |
| Q4 2019 | $85,000 | -50.0% | 1,605 | -62.7% | 0.00% | -50.0% |
| Q3 2019 | $170,000 | +1788.9% | 4,300 | +1947.6% | 0.00% | – |
| Q2 2019 | $9,000 | -10.0% | 210 | 0.0% | 0.00% | – |
| Q1 2019 | $10,000 | +11.1% | 210 | 0.0% | 0.00% | – |
| Q4 2018 | $9,000 | -25.0% | 210 | 0.0% | 0.00% | – |
| Q3 2018 | $12,000 | +20.0% | 210 | 0.0% | 0.00% | – |
| Q2 2018 | $10,000 | +25.0% | 210 | 0.0% | 0.00% | – |
| Q1 2018 | $8,000 | -46.7% | 210 | -41.7% | 0.00% | – |
| Q4 2017 | $15,000 | +15.4% | 360 | 0.0% | 0.00% | – |
| Q3 2017 | $13,000 | +18.2% | 360 | 0.0% | 0.00% | – |
| Q2 2017 | $11,000 | +83.3% | 360 | +71.4% | 0.00% | – |
| Q1 2017 | $6,000 | -40.0% | 210 | -47.5% | 0.00% | – |
| Q4 2016 | $10,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 938,490 | $120,070,000 | 33.50% |
| Foresite Capital Management III, LLC | 108,630 | $13,898,000 | 16.15% |
| Octagon Capital Advisors LP | 112,363 | $14,376,000 | 4.98% |
| Artal Group S.A. | 1,400,000 | $179,116,000 | 3.84% |
| Avoro Capital Advisors LLC | 1,550,000 | $198,307,000 | 3.42% |
| Affinity Asset Advisors, LLC | 45,000 | $5,757,000 | 3.05% |
| NWI MANAGEMENT LP | 200,000 | $25,588,000 | 2.54% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 71,000 | $9,063,000 | 2.48% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,600,000 | $332,644,000 | 2.00% |
| Parkman Healthcare Partners LLC | 52,458 | $6,711,000 | 1.72% |